Summary
Johnson & Johnson (JNJ) filed an 8-K on July 13, 2015, to announce its second-quarter results for the period ended June 28, 2015. The filing primarily consists of a press release and supplementary financial data, which investors can use to assess the company's recent financial performance. Investors should review the detailed sales and earnings information released to understand the drivers behind JNJ's performance in the quarter and any potential implications for future financial periods. The press release and supplementary data are the key components of this filing for understanding the company's operational and financial standing as of that date.
Key Highlights
- 1Johnson & Johnson released its second-quarter 2015 financial results on July 14, 2015, via an 8-K filing.
- 2The report includes a press release detailing sales and earnings for the quarter ended June 28, 2015.
- 3Unaudited comparative supplementary sales data and condensed consolidated statements of earnings for the second quarter are provided.
- 4This filing serves as the primary source for investors to obtain JNJ's latest financial performance figures.
- 5The information in this 8-K is crucial for evaluating the company's operational performance during the second quarter of 2015.
Frequently Asked Questions
The main purpose of this 8-K filing is to publicly announce and provide details on Johnson & Johnson's financial results for the second quarter ended June 28, 2015. It includes a press release and supplementary financial data for investors.
The filing includes a press release announcing second-quarter sales and earnings, as well as unaudited comparative supplementary sales data and condensed consolidated statements of earnings for the second quarter.
The detailed financial results are contained within the press release (Exhibit 99.15) and the supplementary sales data and condensed consolidated statement of earnings (Exhibit 99.2O) attached to this 8-K filing.